According to a recent LinkedIn post from Forge Biologics, the company is recruiting a Senior Associate Scientist for its Manufacturing Sciences & Technology (MS&T) team, focused on downstream gene therapy manufacturing. The role is described as supporting development, optimization, and ongoing support of scalable, compliant, and production‑ready processes for client programs.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests Forge is adding technical depth in downstream processing, a critical capability for gene therapy contract development and manufacturing organizations. For investors, this hiring focus may indicate sustained or growing demand from clients, continued investment in process robustness and reliability, and an emphasis on enabling late‑stage and commercial‑scale production in a competitive advanced therapies manufacturing market.